Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Increased Intra-abdominal Pressure Induces Acute Kidney Injury in an Experimental Model of Congestive Heart Failure.

Abu-Saleh N, Aronson D, Khamaisi M, Khoury EE, Awad H, Kabala A, Ramadan R, Karram T, Kakiashvili E, Bishara B, Abassi Z.

J Card Fail. 2019 Jun;25(6):468-478. doi: 10.1016/j.cardfail.2019.03.008. Epub 2019 Mar 14.

PMID:
30880249
2.

Dataset on mice body weights and food intake following treatment with PG545.

Kinaneh S, Agbaria M, Abu-Saleh N, Hamoud S.

Data Brief. 2018 Sep 6;20:1305-1308. doi: 10.1016/j.dib.2018.08.179. eCollection 2018 Oct.

3.

Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E0 mice.

Muhammad RS, Abu-Saleh N, Kinaneh S, Agbaria M, Sabo E, Grajeda-Iglesias C, Volkova N, Hamoud S.

Atherosclerosis. 2018 Sep;276:155-162. doi: 10.1016/j.atherosclerosis.2018.07.026. Epub 2018 Jul 24.

PMID:
30075439
4.

Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages.

Grajeda-Iglesias C, Rom O, Hamoud S, Volkova N, Hayek T, Abu-Saleh N, Aviram M.

Biofactors. 2018 May;44(3):245-262. doi: 10.1002/biof.1415. Epub 2018 Feb 5.

5.

Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout Mice.

Hamoud S, Shekh Muhammad R, Abu-Saleh N, Hassan A, Zohar Y, Hayek T.

Biomed Res Int. 2017;2017:7357495. doi: 10.1155/2017/7357495. Epub 2017 Oct 26.

6.

Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism.

Rom O, Grajeda-Iglesias C, Najjar M, Abu-Saleh N, Volkova N, Dar DE, Hayek T, Aviram M.

J Nutr Biochem. 2017 Jul;45:24-38. doi: 10.1016/j.jnutbio.2017.02.023. Epub 2017 Apr 6.

PMID:
28431321
7.

The role of high density lipoprotein in Type 1 Gaucher disease.

Watad S, Abu-Saleh N, Yousif A, Agbaria A, Rosenbaum H.

Blood Cells Mol Dis. 2018 Feb;68:43-46. doi: 10.1016/j.bcmd.2016.11.005. Epub 2016 Nov 12.

PMID:
27876360
8.

Eastern Mediterranean Health Journal (EMHJ): a 20-year overview (1995-2014).

Mandil A, Curlet F, El-Din HN, Abu-Saleh N, Soliman M.

East Mediterr Health J. 2016 Nov 2;22(8):628-637. Review.

9.

Aqueous or lipid components of atherosclerotic lesion increase macrophage oxidation and lipid accumulation.

Abu-Saleh N, Aviram M, Hayek T.

Life Sci. 2016 Jun 1;154:1-14. doi: 10.1016/j.lfs.2016.04.019. Epub 2016 Apr 23.

PMID:
27114099
10.

Correction: The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport.

Ismael-Badarneh R, Guetta J, Klorin G, Berger G, Abu-Saleh N, Abassi Z, Azzam ZS.

PLoS One. 2015 Aug 26;10(8):e0137118. doi: 10.1371/journal.pone.0137118. eCollection 2015. No abstract available.

11.

The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport.

Ismael-Badarneh R, Guetta J, Klorin G, Berger G, Abu-Saleh N, Abassi Z, Azzam ZS.

PLoS One. 2015 Jul 31;10(7):e0134175. doi: 10.1371/journal.pone.0134175. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137118.

12.

Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.

Cohen-Segev R, Francis B, Abu-Saleh N, Awad H, Lazarovich A, Kabala A, Aronson D, Abassi Z.

Acta Histochem. 2014 Oct;116(8):1342-9. doi: 10.1016/j.acthis.2014.08.006. Epub 2014 Sep 10.

PMID:
25217176
13.

Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples.

Nakhleh MK, Amal H, Awad H, Gharra A, Abu-Saleh N, Jeries R, Haick H, Abassi Z.

Nanomedicine. 2014 Nov;10(8):1767-76. doi: 10.1016/j.nano.2014.06.007. Epub 2014 Jun 19.

PMID:
24954383
14.

Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury.

Abu-Saleh N, Awad H, Khamaisi M, Armaly Z, Karram T, Heyman SN, Kaballa A, Ichimura T, Holman J, Abassi Z.

Am J Physiol Renal Physiol. 2014 Jan 1;306(1):F24-33. doi: 10.1152/ajprenal.00379.2013. Epub 2013 Nov 6.

15.

Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide.

Naffaa M, Abu-Saleh N, Awad H, Khamaysi I, Karram T, Azzam ZS, Abassi Z, Bishara B.

Surg Endosc. 2013 Jul;27(7):2517-25. doi: 10.1007/s00464-012-2773-7. Epub 2013 Jan 26.

PMID:
23355167
16.

Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure.

Bishara B, Abu-Saleh N, Awad H, Ghrayeb N, Goltsman I, Aronson D, Khamaysi I, Assady S, Armaly Z, Haddad S, Haddad E, Abassi Z.

Eur J Heart Fail. 2012 Oct;14(10):1104-11. Epub 2012 Jun 27.

17.

Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model.

Abu-Saleh N, Ovcharenko E, Awad H, Goltsman I, Khamaisi M, Hoffman A, Heyman SN, Winaver J, Abassi Z.

Life Sci. 2012 Oct 15;91(13-14):669-75. doi: 10.1016/j.lfs.2012.02.002. Epub 2012 Feb 17.

18.

Pneumoperitoneum aggravates renal function in cases of decompensated but not compensated experimental congestive heart failure: role of nitric oxide.

Bishara B, Abu-Saleh N, Awad H, Goltsman I, Ramadan R, Khamaysi I, Abassi Z.

J Urol. 2011 Jul;186(1):310-7. doi: 10.1016/j.juro.2011.03.040. Epub 2011 May 20.

PMID:
21600609
19.

Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat.

Ovcharenko E, Hansen MK, Goltsman I, Abu-Saleh N, Abassi Z, Walsh K, Miele G, Feuerstein GZ, Winaver J.

Nephron Physiol. 2010;115(3):p21-30. doi: 10.1159/000314541. Epub 2010 May 12.

PMID:
20460939
20.

Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure.

Bishara B, Ramadan R, Karram T, Awad H, Abu-Saleh N, Winaver J, Assadi A, Abassi Z.

Surg Endosc. 2010 Apr;24(4):826-33. doi: 10.1007/s00464-009-0672-3. Epub 2009 Aug 26.

PMID:
19707822
21.

Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.

Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, Levy AP.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F830-8. doi: 10.1152/ajprenal.90655.2008. Epub 2009 Jan 28.

22.

Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.

Bishara B, Shiekh H, Karram T, Rubinstein I, Azzam ZS, Abu-Saleh N, Nitecki S, Winaver J, Hoffman A, Abassi ZA.

J Pharmacol Exp Ther. 2008 Aug;326(2):414-22. doi: 10.1124/jpet.108.137745. Epub 2008 May 8.

PMID:
18467593

Supplemental Content

Loading ...
Support Center